logo

ASPI

ASP Isotopes·NASDAQ
--
--(--)
--
--(--)
9.10 / 10
Outperform

Comprehensive fundamental analysis yields a top-tier 9.1/10 score for ASP Isotopes. Key bullish factors include strong PB-ROE (2.5183, Group 4), robust Profit-MV (0.4634, Group 2), and a healthy Total profit / EBIT ratio (97.0137, Group 3). However, certain areas lag, such as Net assets per share growth (Group 1) and Cash-UP (Group 1), which temper the overall outlook. The balance of these metrics supports an Outperform rating but highlights pockets that need monitoring.

Fundamental(9.1)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-3.17
Score2/3
Weight14.44%
1M Return2.48%
Net assets per share (growth rate compared to beginning of year %)
Value19.35
Score0/3
Weight-13.98%
1M Return-2.70%
Net profit attributable to parent company shareholders / Net profit (%)
Value99.87
Score2/3
Weight7.67%
1M Return1.25%
Profit-MV
Value0.46
Score3/3
Weight45.07%
1M Return5.77%
Net income-Revenue
Value-0.17
Score2/3
Weight4.49%
1M Return0.74%
PB-ROE
Value2.52
Score3/3
Weight22.84%
1M Return3.54%
Total profit / EBIT (%)
Value97.01
Score3/3
Weight25.70%
1M Return3.80%
Cash-UP
Value-0.06
Score1/3
Weight-13.79%
1M Return-2.49%
Asset-MV
Value-0.50
Score0/3
Weight-7.99%
1M Return-1.31%
Cash-MV
Value-0.07
Score3/3
Weight15.55%
1M Return2.70%
Is ASPI undervalued or overvalued?
  • ASPI scores 9.10/10 on fundamentals and holds a Discounted valuation at present. Backed by its -130.45% ROE, -1261.23% net margin, -6.45 P/E ratio, 6.67 P/B ratio, and -137.29% earnings growth, these metrics solidify its Outperform investment rating.